Company intelligence / Profile preview

LKT Laboratories

St. Paul, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

LKT Laboratories supplies high-purity specialty chemicals and small molecules, including inhibitors and modulators, for use in life science research; products are used broadly in cancer biology, neuroscience, and other indications. The company does not have clinical programs or trial results

Therapeutic areas: ImmunologyEndocrinologyMetabolic DisordersInfectious DiseasesCardiovascularOncologyNeurology
Modalities: Small moleculePeptides
Industry: Chemicals & Materials

Partnerships

Partnerships with Chinese and other international distributors (no major pharma/biotech announced)

Beyond the preview

Go deeper on LKT Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LKT Laboratories.

Explore the full profile